MEDNAX Announces Acquisition of Anesthesiology Practice in Texas

  MEDNAX Announces Acquisition of Anesthesiology Practice in Texas

Business Wire

FORT LAUDERDALE, Fla. -- May 30, 2013

MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Anesthesia
Specialists of Houston, L.L.P., a physician group practice based in Houston,
Texas. The practice will become part of MEDNAX’s American Anesthesiology
division and is the third Texas-based anesthesiology practice to join this
division.

Anesthesia Specialists of Houston has been serving the Greater Houston
metropolitan area since 1981 and is a private group practice consisting of 9
anesthesiologists, 30 anesthetists and 9 other clinical and administrative
support staff. The practice provides anesthesia services at The Woman's
Hospital of Texas, which is dedicated solely to the health of women and
newborns, as well as at Fannin Surgicare, an outpatient ambulatory surgical
center.

MEDNAX’s Pediatrix Medical Group division currently provides neonatal
intensive care services at The Woman's Hospital of Texas.

“We wanted to be part of American Anesthesiology for reasons that go beyond
the many challenges we face in the future of healthcare,” said Hector
Santiago, M.D., who will serve as medical director for the practice. “Not only
does MEDNAX already have an excellent relationship with The Woman’s Hospital
of Texas through their NICU, but the company’s unparalleled experience and
resources, and the fact that its physicians and leadership place a high value
on clinical research, education and quality is what convinced us that we found
the right partner.”

MEDNAX’s American Anesthesiology division consists of more than 1,600
anesthesia providers, including more than 650 physicians and 950 anesthetists
practicing in North Carolina, Florida, Georgia, Michigan, New Jersey,
Tennessee, Texas, and Virginia.

This practice was acquired for cash and the transaction is expected to be
immediately accretive to earnings. No additional terms of the transaction were
disclosed.

ABOUT MEDNAX

MEDNAX, Inc. is a national medical group that comprises the nation's leading
provider of neonatal, maternal-fetal and pediatric physician subspecialty
services as well as anesthesia services. Physicians and advanced practitioners
practicing as part of MEDNAX are reshaping the delivery of care within their
specialties and subspecialties, using evidence-based tools, continuous quality
initiatives and clinical research to enhance patient outcomes and provide
high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX,
was founded in 1979 and now includes neonatal physicians who provide services
at more than 330 neonatal intensive care units, who collaborate with
affiliated maternal-fetal medicine, pediatric cardiology and pediatric
critical care physician subspecialists to provide a clinical care continuum.
Pediatrix is also the nation's largest provider of newborn hearing screens. In
2007, MEDNAX expanded into anesthesia services. Today, American Anesthesiology
includes more than 1,600 anesthesiologists and advanced practitioners who
provide anesthesia care to patients in connection with surgical and other
procedures as well as pain management. MEDNAX, through its affiliated
professional corporations, employs more than 2,150 physicians in 34 states and
Puerto Rico. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to
contain forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements may include, but are not limited to,
statements relating to our objectives, plans and strategies, and all
statements, other than statements of historical facts, that address
activities, events or developments that we intend, expect, project, believe or
anticipate will or may occur in the future. These statements are often
characterized by terminology such as “believe”, “hope”, “may”, “anticipate”,
“should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”,
“positioned”, “strategy” and similar expressions, and are based on assumptions
and assessments made by MEDNAX’s management in light of their experience and
their perception of historical trends, current conditions, expected future
developments and other factors they believe to be appropriate. Any
forward-looking statements in this press release are made as of the date
hereof, and MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and are
subject to risks and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially from
forward-looking statements are described in MEDNAX’s most recent Annual Report
on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections
entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed
with the Securities and Exchange Commission.

Contact:

MEDNAX, Inc.
David T. Parker, 954-384-0175, Ext. 5300
Vice President, Investor Relations & Corporate Communications
david_parker@mednax.com